Total number of patients |
39 |
244 |
|
Year of transplant (range) |
1986–1993 |
1986–1993 |
|
Mean age at transplant (years) |
35.0 ± 6.1 |
35.4 ± 5.9 |
0.67 |
Male |
22 (56.4%) |
151 (61.8%) |
0.51 |
Race: |
|
|
0.49 |
Caucasian |
39 (100%) |
241 (98.7%) |
Bladder drained pancreas duct |
38 (97.4%) |
225 (92.2%) |
0.24 |
Induction immunosuppressive medication |
|
|
0.86 |
Minnesota anti-lymphocyte globulin (MALG) |
7 (17.9%) |
41 (16.8%) |
OKT3 |
32 (82%) |
203 (83.1%) |
Pancreas graft outcomes: |
All functional |
|
|
Death with functional graft |
90 (36.7%) |
Resumption of moderate- to high-dose insulin |
97 (39.6%) |
Graft removed |
29 (11.8%) |
Other (Transferred to a different center, death with unknown pancreas graft function) |
29 (11.8%) |
Mean pancreas graft survival at last follow up (years) |
27.5 ± 1.9 |
9.8 ± 7.5 |
<0.001 |